Cryoablation Devices Market 2018: Global Industry Analysis, Size, Share, Growth, Trends and Forecast To 2026

Cryotherapy and radiofrequency ablation (RFA) are the two clinically viable ablation modalities that are widely used and cryotherapy is a treatment that uses extreme cold for denaturing the diseased tissues in the human body. In cryoablation therapy, liquid nitrogen or argon gas is passed to the site of treatment using a probe, which creates intense cold that freezes the internal tumors. The procedure is often carried out multiple times till the affected tissue is totally destroyed. The technique yields high effectiveness for treatment of various tumors such as that in the bones, kidneys, breasts, lungs, and liver, and can also be used to treat certain skin conditions. The probe is guided using MRI and ultrasound, which locates the exact position of the affected tissue that proves the specificity of the therapy.

Some of the major companies in cryoablation devices market are Medtronic Inc, Galil Medical Inc, AtriCure, Inc., IceCure Medical and Sanarus Technologies.

Request For Sample Copy of This Research Report: www.coherentmarketinsights.com/insight/request-sample/113

Continuous development and innovation into probes are expected to favor increase in adoption rate for cryoablation devices in the near future. Increase in geriatric population is expected to be a major push for the market to grow in emerging countries such as China, according to United Nations Department of Economic and Social Affairs (U.N. DESA), there were 125 million people aged 80 years or over in 2015, which is expected to increase to 434 million by 2050. This rise in geriatric population will support the growth of cryoablation devices for the treatment of the elderly people who cannot undergo open heart surgery.

Market Taxonomy

This report segments the global cryoablation devices market on the basis of device type, application, end user and geography. On the basis of device type, the market is categorized into systems and probes. Among these, probes segment dominate the cryoablation devices market. On the basis of application, the market is divided into prostate cancer, renal cancer, liver cancer, breast cancer and cardiac arrhythmia. On the basis of geography, the market is divided into 6 regions.

Key features of the study:

This report provides in-depth analysis of the cryoablation devices market and provides market size (US$ Mn) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2017–2025)

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline technologies, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global cryoablation devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans

According to the World Health Organization (WHO), the number of new cancer cases is expected to increase by 70% by 2030 as compared to 2012. This increase in cancer cases will support growth of cryoablation devices market, as cryoablation is a preferred treatment for cancer. The change in lifestyle and unhealthy eating habits, along with increasing consumption of tobacco and alcohol is the leading cause for growth in number of cancer cases. As per stats released by National Cancer Institute (NCI), around 1,685,210 new cases of cancer were diagnosed in the U.S. in 2016.

Increase in incidence of cardiac disorders such as cardiac arrhythmia, atrial fibrillation, and atrial flutter expected to fuel the growth in cryoablation devices market

According to Centers for Disease Control and Prevention (CDC), every year, around 610,000 people die due to heart disease in the U.S. Furthermore, around 2.7 to 6.1 million people were suffering from atrial fibrillation in 2013-14 in the U.S., the high incidence of cardiac disorders such as cardiac arrhythmia, atrial fibrillation, and atrial flutter is the another factor leading to the growth of cryoablation devices market.

The growing aging population and obesity rate are the major risk factor for atrial fibrillation. As per W.H.O., worldwide obesity has more than doubled and it is reached to more than 1.9 billion obese population in 2014 from 1980, as well as around 41 million children under the age of 5 were obese in 2014 and this number is continuously on rise in emerging countries. As per the stats of W.H.O. around 10.6 million children who are obese found in Africa in 2014, also close to half of the children under 5 who were obese lived in Asia in 2014. This increase in number of obese population in emerging countries will support to expand the customer base for companies in untapped market.

Click To Read More On Cryoablation Devices Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Peanut Allergy Vaccine Market Analysis, Key Players, Market Share, Demand/Supply Chain and Forecast to 2026

Allergies are medical conditions caused primarily by hypersensitivity of the immune system to some external stimulus. Allergy may cause anaphylaxis—a medical condition that can cause irritation of the skin, swelling of throat, shortness of breath, and in some cases, death. Allergies are caused by various allergens such as pollen grains, or certain foods such as peanuts. Vaccination is the process of administering antigenic material or a vaccine to stimulate one’s immune system to build up an adaptive immunity to pathogens.

Companies operating in the market in the current scenario are focusing on obtaining approval for their products from the respective regulatory bodies. The major companies operating in the market are Allergy Therapeutics, Zicam, Aravax, Immunomic Therapeutic, Inc., Astellas, and Aimmune.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/121

Food allergy is one of the major forms of allergies. Food allergies can be caused by cow’s milk, eggs, shellfish, and many other foods, including peanuts. However, peanut allergy is very prevalent in the present scenario, especially in children. Therefore, peanut allergy vaccine market is likely to gain significant traction in the near future. Peanut allergy vaccine is administered to patients who are detected with a probability of developing peanut allergy, so as to prevent occurrences of allergy attacks such as anaphylaxis in the future. According to a report published by National Centre for Biotechnology Information, allergy to peanuts as well as tree nuts (TNs) is the principal reason for fatal allergic reactions in the U.S., and the occurrences appear to be rising. In this 11 year follow up research, over 1% (around 3 million) people reported peanut or tree nut allergies and the condition has been on the rise, mainly amongst children. According to a report by Food Allergy Research and Education (FARE), peanuts caused the most number of allergies in the U.S., among all food allergens. Hence, peanut allergy vaccine market has a major potential for growth in this region during the forecast period (2018–2026).

Peanut Allergy Vaccine Market Taxonomy

On the basis of end user, the global peanut allergy vaccines market is classified into:

Hospitals

Medical Practitioners

Government Agencies

Personal Clinics

Others

Government initiative towards creating awareness and regulatory approvals for peanut allergy vaccine is necessary for the growth of the market. Some of the other treatment methods for peanut allergy are oral immunotherapy and epinephrine treatment. However, neither of these treatments has gained significant momentum in the peanut allergy treatment market.

Peanut Allergy Vaccine Market Outlook – Increasing prevalence of peanut allergy and lack of proper treatment

Globally, incidence of peanut allergy is increasing supported by rising birth rate. The risk of peanut allergy is more prevalent in countries such as the U.K., Australia, and the U.S. According to American Academy of Allergy Asthma & Immunology, 30.4% of the children with food allergies suffered from multiple allergy attacks. Peanut allergy is such an epidemic condition in the U.S. that the federal Food Allergen Labeling and Consumer Protection Act (FALCPA) mandated that all packaged food sold in the U.S. that include peanuts as an ingredient have to prominently display the word ‘Peanut’ on the label. The only solution to peanut allergy is restraining a patient from having peanuts/peanuts containing products. Nevertheless, peanut vaccine is capable of curing the ailment from a very young age, without any restriction on food.

Click To Reading More On Peanut Allergy Vaccine Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Dental 3D Printing Devices Market is Growing at a Remarkable CAGR 2018-2026

Dental 3D printing is additive manufacturing used to create 3-dimentional image for incorporating several layer of image for building material. These objects are produced from a digital 3D blueprint like a computer-aided design or MRI scan. These devices allow the designers to make changes in the design without any additional tool or equipment. Dental 3D printing combines high quality 3D printing technology with a wide variety of dental materials. This technology is adopted by dentists, orthodontists, and dental labs. It is cost effective and allows for extensive customizations that allow for better designing. This allows dental practitioners to design the product based on the various factors of patient like age, height, weight, and medical history. These methods can be used by dental practitioners to replace teeth, veneers, crowns, and inlays in a single sitting.

Request Sample Copy Of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/105

Global Dental 3D Printing Devices Market Taxonomy:

The global dental 3D printing devices market is classified on the basis of the following segments product type, technique, application, and end user of the dental 3D printing device:

Product Type:

Printers

Software

Components

Technique:

Digital Light ProjectionDental 3D Printing Devices Market Outlook,

Dental 3D Printing Devices Market Share,

3D Jet Printing

Stereo Lithography Apparatus (SLA) 3D Printing

Selective Laser Sintering (SLS)

Direct Laser Metal Sintering (DLMS)

Application Type:

Orthopedic Implants

Dental Restoratives

Crowns

Surgical instruments

Others

Dental 3D printing allows designing of dental crowns, prosthetics, implants, bone replacement, and customized devices based on requirement.

Major dental 3D printing devices: Planmeca Creo (Planmeca), Form 2 (Formlabs), Mysint 100 (Sisma 3D), Moonray (SpintRay), Projet MJP 3600 (3D Systems), Project 6000(3D Systems), Roboze one (Roboze S.r.l.) etc.

Increasing influx of dental tourists and cost-effectiveness of 3D printed devices to fuel market growth

Developed economies such as the U.S., U.K., Germany, and France experience high rate of adoption due to better healthcare facilities and easy availability in these countries. As per the report of the American Academy of Periodontology, in 2012, around half of the adult population in the U.S. suffered from gum disease, of which 47.2% were reported to be suffering from periodontitis. This number is expected to increase significantly over the forecast period, owing to increasing changes in lifestyle and growing geriatric population Increasing number of dental clinics and hospitals and growing number of experienced dental practitioners in Asia Pacific region, supplemented by rising influx of dental tourists is expected to significantly boost growth of the dental 3D printing devices market in these regions.

Devices with comprehensive range of features

Companies are focusing on launching new devices to the market with advanced features and technology to provide better imaging facilities to the practitioners for service, for instance, GE Healthcare are prepared to utilize 3-D printing technology in ultrasound probes previously used in medical services for diagnosing the health of a fetus, although now the technique is useful where any type of noninvasive inspections are being carried out. Furthermore, in March 2015, Germany-based Bego launched a new system with a unique cartilage system that allow multiple materials to be used at the International Dental Show. In May 2016, Planmeca launched a new 3D printer with powerful 3D features that fulfills demands of cheap and high quality image of additive manufacturing in healthcare.

Click To Reading More On Dental 3D Printing Devices Market

Fragmented Market

The global dental 3D printing devices market is highly fragmented, owing to the participation of many established and emerging players in the dental imaging market. Various players in the dental 3D printing devices market are integrating proprietary technologies of 3D printing to develop with novel products and product advancements in order to differentiate their offerings. For example, 3D System Corporation projet 3510 MP would use 3Shape Implant Studio, which includes implant planning and surgical guides for the patient that benefits the patients by reducing chair time and provides digital accuracy by reducing manual errors. The combination is expected to manufacture fully functional dental implants. Some of the major players involved in the dental 3D printing devices market are EnvisionTEC, Javelin Technologies, Formlabs Inc., 3D Systems GMBH, Stratasys, Prodways, Roboze, and ASIGA.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Oxygen Therapy Market – Global Industry – Key Players, Economic Impact, Cost and Revenue from 2018-2026

Oxygen therapy is the use of oxygen as medical intervention to maintain enough oxygen in conditions such as hypoxia, hypoxemia, and other related conditions. Oxygen may be administered through a nasal cannula, face mask, or through hyperbaric oxygen chamber. This therapy helps maintain oxygen level in the blood for treatment of acute and chronic diseases such as chronic obstructive diseases (COPD), pneumonia, and asthma. Long-term therapy with oxygen is often useful in people suffering from COPD. Certain other acute or chronic disease conditions where oxygen therapy is effective include cystic fibrosis, dysplasia, heart failure, sleep apnea, and lung disorders.

Request Sample Copy Of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/97

Oxygen therapy market taxonomy

The global oxygen therapy market is segmented on basis of source equipment, application, delivery device, and end use. By type of source equipment, the market in oxygen therapy is segmented into oxygen cylinders, liquid oxygen devices, and oxygen concentrators. On the basis of device type, the the oxygen therapy industry is segmented into nasal cannula, face mask, bag valve mask, venturi mask, oxygen mask, non-rebreather mask, and CPAP devices. On the basis of application, the global oxygen therapy market is as asthma, cystic fibrosis, COPD, pneumonia, respiratory distress syndrome, and cardiovascular diseases.

Oxygen therapy is used in hospitals to cure patients suffering from respiratory diseases such as COPD and pneumonia, and also cardiovascular diseases fueling growth of the oxygen therapy market. Oxygen therapy is also used in clinics, rehabilitations centers and home care settings .

Increasing incidence of COPD and lung disorders drive growth of the oxygen therapy market across the globe

Factors such as high prevalence of respiratory related diseases, growing aging population, and increasing vulnerability of the populace to respiratory conditions are fueling growth of the oxygen therapy market in North America. According to the Center for Diseases Control and Prevention (CDC), around 15.7 million people in the U.S. were diagnosed with COPD in 2013. Other factors driving demand for oxygen therapy include innovation in portable oxygen concentrators, rise in number of untreated sleep apnea cases, favorable reimbursement scenario, growing demand for oxygen filling devices, good medical facilities, and high investment in research and development activities. The European market in oxygen therapy is also gaining traction in recent times, mainly fueled by increasing number of patients suffering from respiratory diseases and favorable government initiatives to facilitate respiratory care.

According to the World Health Organization, over 90% of COPD deaths occur in low income and middle income countries. Therefore, the oxygen therapy market is expected to grow substantially in African, Asian, and Latin American countries due to high prevalence of COPD and deaths due to the disease. Furthermore, increasing awareness among medical facilities, increasing government investment in healthcare facilities, and availability of low cost treatment is projected to drive demand for oxygen therapy in emerging economies.

Alarming increase in number of lung damage cases increasing demand for oxygen therapy for effective treatment

According to World Health Organization (WHO) over 3 million people die each year due to COPD. Increasing use of oxygen therapy in treatment of diseases such as COPD, asthma, obstructive sleep apnea, and respiratory distress syndrome is a supportive prevalent trend in the market. Long-term oxygen therapy for patients suffering from chronic lung disease can help improve quality and length of life, in turn creating a favorable environment for the market. Increasing risk of lung damage due to tobacco consumption, occupational hazards, and pollution would further augment market growth over the following decade.

Global players engaged in the oxygen therapy market

There are several medical device companies, both local player and global ones, engaged in manufacture of oxygen therapy devices. Some of the prominent players are Respironics, Inc. (a Philips company), Fisher & Paykel Healthcare Limited, Teleflex Incorporated, Invacare Corporation, AirSep Corporation, CareFusion Corporation, DeVilbiss Healthcare, MAQUET Holding B.V. & Co. KG, and ResMed, Inc.

Click To Read More On Oxygen Therapy Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Why the Dental Implants Market is a Growing Payer Opportunity?

Dental implants are implants in the jaw, placed below the gum line, providing a base for planting artificial teeth or bridge. Dental implants market has witnessed drastic rise in the last few years. A number of socioeconomic and technological factors have contributed to overall growth of the industry. Europe and North America account for 65.9% of global dental implants market revenue in 2016. However, market dynamics are expected to witness a major shift, with Asia Pacific and Latin America emerging as the fastest growing markets for dental implant over the forecast period (2016–2024). This is primarily attributed to aging baby boomers population with high spending power. Lately, the industry is witnessing change in market dynamics post-economic recession of 2008. The industry that was once fragmented is slowly shifting towards consolidation. One such example is the acquisition of Astra by DENTSPLY in 2011.

Market Dynamics

With changing market dynamics, companies are emphasizing on product innovation and strengthening of distribution channel to sustain and expand their business reach worldwide. Various macroeconomic factors such as increased geriatric population, growing focus on aesthetics, rise in out-of-pocket spending, and establishment of quality healthcare institutions are expected to bolster sales of dental implant devices worldwide. On an average, over 20% of population in EU is aged over 65 years. Moreover, EU spends nearly 9% of its GDP on healthcare. Increasing consolidation, technological advancement, and company laying emphasis on strengthening distribution channels are some of the key dental implants market trends.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/89

Market Taxonomy

This report segments the dental implants market on the basis of product type, technique, population demographics, and end use. On the basis of product type, the market is segmented into titanium and zirconium. On the basis of technique, the dental implants market is segmented as root form and plate form. On the basis of population demographics, the market is segmented into geriatric, middle-aged, adult, and others. On the basis of end-use, the dental implants market is segmented as dental labs, hospitals, and others.

Key features of the study:

This report provides in-depth analysis of the dental implants market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2016 – 2024), considering 2015 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

The report takes into account critical limiting factors such as accuracy issues and need for calibrating the device several times a day while analyzing the market value and growth (%) during the forecast period

It includes insights on population dynamics, number of dental clinic centers, and demand for dental implants across the globe.

Europe is expected to dominate the market throughout the forecast period. The region is expected to account for 30.8% of overall market share by 2024. Competition in dental implants market has increased primarily between Straumann and DENTSPLY Implants. According to Europa, over 25% of the population in Europe is expected to fall under geriatric age group by 2020. This coupled with high discretionary income in the region is expected to continue to position the region as a highly lucrative market for dental implants. Germany is one of the key markets for dental implants. The country spends highest per capita income on teeth than any other country in Europe.

Among product type, titanium dental implants segment is expected to hold dominant position in the dental implants market over the forecast period. The segment accounted for 44.7% of global market revenue in 2015. However, zirconia dental implants segment is expected to hold dominant position in the market by 2024. Key players are launching mini-titanium dental implants solutions, which are compatible with biologically active drugs that are usually incorporated on the surface of implant to improve osseointegration. The consumers mostly prefer titanium dental implants, as it has longer lifespan.

Emerging economies to present highly lucrative growth avenues

Dental implant players are focused towards strengthening of direct distribution channel along with partnership with regional manufacturers and distributors. DENTSPLY Implants, Straumann AG, Bicon Dental Implants, Anthogyr, KYOCERA Medical Corporation, Lifecore Dental Implants, Zest Anchors, Implant Innovations Inc, and BioHorizons IPH, Inc., Neobiotech USA. Inc., Sweden & Martina, TBR Implants Group, Global D, and MOZO-GRAU, S.A. are some of the key industry players in dental implants market.

Click To Read More On Global Dental Implants Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Breast Pumps Market Poised to Take Off by 2026

Breast pump devices enable women to express breast milk and store it for later use. These are especially useful for working mothers nursing a newborn. Breast pumps gaining eligibility for reimbursement under the Affordable Care Act is a key trend promoting its adoption in the U.S. Working mothers usually prefer automatic electronic breast pumps. These automatic breast pumps have adjustable suction level and variable cycling time, which offers enhanced comfort to the use. Double pumps help reduce pumping time as they drain both breasts simultaneously and more effectively.

Request For a Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/81

Market Taxonomy

This report segments the global breast pumps market on the basis of product design, technology and end user. On the basis of product design, the global breast pumps market is segmented as open system and closed system. The market is classified on the basis of technology as manual pumps, single-electric pumps, and double-electric pumps. On the basis of end user, the global breast pumps market is classified as homecare settings, hospitals, and maternity centers.

Key features of the study:

– This report provides in-depth analysis of breast pumps and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2016 – 2024), considering 2015 as the base year

– It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

– This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

– It profiles leading players in the global breast pumps market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

– Key companies covered as a part of this study include Medela AG, Ameda Breastfeeding Solutions, Philips AVENT, Lansinoh Laboratories, Inc., Hygeia Medical Group, Whittlestone, Inc., Bailey Medical, Energizer Personal Care, LLC (Playtex Baby), Jarden Corporation, Handi-Craft Company, and Mayborn Group Limited

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics

Detailed Segmentation:

Global Breast Pumps Market, By Product Design:

Open-system

Closed-System

Global Breast Pumps Market, By Technology:

Manual

Single Electric

Double Electric

Global Breast Pumps Market, By Pumping System:

Homecare settings

Hospitals

Increasing disposable incomes and favorable reimbursement policies driving demand for electric breast pumps

Automated electric pumps with double pump system offer convenience to women in expressing breast milk. Increasing insurance coverage and availability of reimbursement policies is driving adoption of electric breast pumps in developed markets. Aftermarket for electric breast pumps has witnessed major traction in recent years, wherein renting is an affordable option for women, especially in developing countries. The single-electric breast pump segment is projected to expand at a CAGR of 5.9% during the forecast period (2016 – 2024). However, these devices are bulky and cumbersome to carry, inhibiting adoption to a certain extent.

Battery-powered systems are a more practical solution for on-the-go users. Thus, due to better features and benefits offered by electric and battery-powered breast pumps, demand for manually operated breast pumps is projected to experience a downward spiral during the forecast period.

Technologically advanced breast pumps to replace manually operated breast pumps

In November 2016, Medela AG launched Sonata—a smart breast pump connected to a mobile app MyMedela. This system aids mothers to track baby’s activities, get access to expert tips, get real-time notifications, and track specific preset goals.

Click To Read More On Global Breast Pumps Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Rapid Expansion Projected for Residential Intellectual Disability Facilities Market

Residential Intellectual and Developmental Disability Facilities

Intellectual disability refers to people who have been classified by one or more terms such as developmental disability, developmental delay and mental handicap. Recently, people classified as having ‘mental retardation’ are also being referred as having intellectual disability. Usually, people are considered to have intellectual disability if they have greater difficulty than most people with intellectual and adaptive functioning. These limitations are expressed in the person’s conceptual, social and practical everyday living skills. Intellectual disability is usually diagnosed through the use of standardized tests of adaptive behavior and intelligence. The precise number of people having intellectual disabilities is not known. However, the American Association on Intellectual and Developmental Disabilities (AAIDD) estimates that roughly 1.5% to 2.5% of the general population have intellectual disability which translates to roughly 4.6 million to 7.7 million people as per the most recent U.S. Census (2011). Over last 30 years, services provided to the people with intellectual disabilities have been changed radically and the institutional care has been replaced by community residential service in several countries.

Request For a Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/72

The global market for the residential intellectual disability facilities can be segmented on the basis of size of facility, type of facility, mode of operation and geography. Based on the number of beds in the residential intellectual disability facilities the market can be segmented further into 4 to 9, 10 to 19, 20 to 49, 50 to 99, 100 to 199, and 200 & more beds. Besides, there are different types of facilities that provide intellectual disability facilities – hospitals, group homes, private home, intellectual and developmental disability facilities. Based on the mode of operation, the global residential intellectual disabilities market can be segmented into state-run facilities, Medicaid funded services, private large facilities, and privately run small facilities. The demand for these residential facilities is largely dependent on the reimbursement through Medicare and Medicaid programs.

Demand-Supply Gap Persist in the Market

Since 2008, increased federal funding for these programs and the additionally enrolled or eligible people for either of the federal programs, have led to the growth of the residential intellectual disability facilities in the U.S. Although the demand for housing or residential facilities for people with intellectual disabilities has been increasing in the recent years, the adequate supply of such facilities has not kept the required pace. Therefore, there is a huge deficit in the demand and the supply of these facilities. Another major restraint in the market growth is the difficulty in avoiding hospital admission for patients with intellectual disabilities who usually present challenges with their behavior and/or mental health problems.

Increasing support from Governments across the Globe to aid Intellectually Disable Patients

On the basis of geography, the global residential intellectual disability facilities market can be segmented into five major geographies – North America, Europe, Asia-Pacific, Latin America and Rest of the World. Aging population, particularly in North America, and Europe, provide a good market opportunity for the market players. Another driving factor is the increasing age of caregivers. Presently, most of the people affected with intellectual disability reside with family caregivers. Due to the changing demographics, caregivers will also age in the coming years and the shortage of caregivers will create more demand for the residential facilities for intellectually disable individuals. The market for such facilities has been very insignificant in most of the Asian countries and little progress is expected during the forecast period from 2014 to 2023. There are many local and national centers in the developing economies too which offer such facilities. For instance, Muskaan, Sandesh and Alamara Residential Centre for Persons with Developmental Disabilities are the centers that offer residential intellectual disability facilities in India.

There are government and private players in addition to local bodies offering residential intellectual disability facilities – NHS Allegheny Valley School, St. Joseph’s Center, Durham County Community, Residential Support Services, Lutheran Family Services and Arlington County Government.

Click To Read More On Residential Intellectual Disability Facilities Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Portable Brain Injury Scanners Market 2018 Expected Vast Growth By 2026 Including Freelancers, Intake, Trials & Forecast By Application, Technologies

Brain injury is any form of damage caused to the brain either through external force or after birth. A brain injury is generally classified in two types – traumatic and acquired. Traumatic brain injury (TBI) is defined as an alteration in the functioning of brain caused by an external force. Whereas an acquired brain injury is an injury caused to the brain after birth. An acquired brain injury is not hereditary, degenerative, congenital or induced by birth trauma. Examples of acquired brain injury include stroke, tumor, electric shock, hypoxic or anoxic brain injury or lightning strike.

According to the Centers for Disease and Control Injury Prevention Center, the leading causes of traumatic brain injury are falls (40.5%), motor vehicle (14.3%), struck by/against (15%) and assault (10.7%). About 19% of the causes are unknown. Traumatic brain injury results in an estimated 2685 deaths and 37,000 hospitalizations.

Request For a Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/64

In general, there are different types of brain injury – Concussion (TBI), Diffuse Axonal Injury (TBI), Contusion (TBI), Second Impact Syndrome (TBI), Coup-contre coup injury (TBI), Penetrating Injury (TBI), Hypoxic brain injury (ABI), Anoxic brain injury (ABI), Locked in Syndrome (TBI), Open and Closed Head Injuries, and Shaken Baby Syndrome (TBI). These types of brain injuries are usually determined by undergoing the expensive MRI or CT scan at hospitals. A portable device that can help determine the need for undergoing the MRI or CT scan can be of great use during emergency situations, military purpose and ambulance services. A portable brain injury scanner is not the replacement of a computed tomography (CT) scan. It is just a screening tool that helps in identifying high risk patients, requiring prioritization of a CT scan and a neurosurgical treatment. The first such device, Infrascanner Model 1000, was being approved by the U.S. FDA in 2011.

Wide Applications

The portable brain injury scanner can be used in emergency rooms, intensive care units, field hospitals, military, ambulance services, remote locations and in sports medicine. The Infrascanner which uses the near infrared (NIR) technology to screen patients has been deployed for use by the U.S. Marine Corps. Infrascanner is a portable, FDA approved and CE marked device that empowers physicians to understand the current functioning of the brain and identify any symptoms of damage. Besides, emergency care departments can be one of the major users of this device to determine the brain injury.

Yet to Establish in the Developed Regions

The portable brain injury scanners are still to capitalize on the opportunities in the U.S., Canada, and European markets. A head injury usually requires a trip to the hospital and a potentially expensive MRI or CT scan. This device helps to identify the need for a MRI and CT scan before incurring that high cost of scanning. Recently, the Neural Analytics received a USD 3 million funding from the National Institutes of Health to aid in the development of portable brain monitoring platform.

Moreover, this new technology is also desired by the emerging nations like India, China, Brazil, and Russia to help them avoid the risk of complications while transporting a patient with traumatic brain injury to the nearby hospital for a CT scan. With increasing research, the technology will further improve with increase accuracy and integration with information technology for anytime and anywhere accessibility of the reports.

Some of the major players in this market include BrainScope Company, Inc., Neural Analytics, and InfraScan,

Click To Read More On Portable Brain Injury Scanners Market

Interventional Neurology Market Size, Share, Regional Analysis, Emerging Trends, Analysis and Forecasts to 2026

Tissue plasminogen activators (tPAs) are used for treatment of stroke, aneurysms, stenosis, and vascular malformations. A study published in the New England Journal of Medicine stated that Neurointerventional surgery in addition to IV-administered “clot-busting” tissue plasminogen activator (IV-tPA) therapy is more effective than administering IV-tPA alone for the treatment of stroke.

According to the Brain Aneurysm Foundation (BAF), brain aneurysm accounts for around 500,000 deaths each year. BAF estimates that aneurysm is predominant in the age group of 35–60 years. Moreover, globally around 15 million people suffer a stroke every year, as per stats released by the World Heart Federation. High incidence of stroke and brain aneurysm is contributing to increasing demand for interventional neurology devices. Furthermore, introduction of new techniques such as flow diverter and aspiration are propelling demand for interventional neurology devices. The global Interventional neurology market was valued at US$ 1,694.5 million in 2015 and is expected to expand at a CAGR of 5.3% during the forecast period (2016 – 2024).

Market dynamics

Factors such as increasing prevalence of brain aneurysms, and stroke, government programs to decrease the burden of traumatic brain injury, technological advancements plugging treatment gaps and availability of reimbursement are driving demand for neurointerventional devices. However, high cost and negative perception about neurointerventional devices is impacting the demand negatively. Companies are therefore, adopting different strategies such as providing FDA approved on-site training, strategic collaborations, and technology upgrades in order to increase their market presence and engage with customers.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/56

Market Taxonomy

This report segments the interventional neurology market on the basis of product type, technique, therapeutic application and end use. On the basis of product type the market has been segmented into embolic coils, carotid stents, intracranial stents, neurovascular thrombectomy devices, embolic protection devices, and flow diverter devices. On the basis of technique, the market is segmented into Neurothrombectomy Procedure, Cerebal Angiography Technique, Stenting Technique, Coiling Procedure Technique, and Flow Disruption Technique. The therapeutic application of interventional neurology devices include brain aneurysm, ischemic strokes, artery stenosis, vein stenosis and others. In terms of end use, the global interventional neurology market is analyzed for hospitals and ambulatory centers. The market is also analyzed across major geographies namely North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

Key features of the study:

  • This report provides in-depth analysis of neurointerventional devices and their usage preferences
  • This study provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2016 – 2024), considering 2015 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this industry
  • This study provides vital insights about market drivers, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the market players
  • The report takes into account these factors in addition to the critical limiting factors and evolving industry trends while analyzing the market value and growth (%) during the forecast period

Detailed Segmentation:

  • Global Interventional Neurology Market, By Product Type:
    • Embolic coils
    • Carotid stents
    • Intracranial stents
    • Neurovascular thrombectomy devices
    • Embolic protection devices
    • Flow diverter devices
    • Intravascular Devices
    • Liquid Embolic Devices
    • Balloons
    • Stent Retrievers

Market players need to address demand-shift in devices and procedural techniques

The global Interventional neurology market is undergoing a demand-shift in terms of products and techniques to treat stroke and aneurysms. For instance, demand for bare platinum coils is growing at a rapid pace as compared to that for coated coils. This is mainly due to high costs of coated coils and their less improved clinical outcomes compared to bare platinum coils. The highly touted International Subarachnoid Aneurysm Trial (ISAT) demonstrated improved clinical outcomes with coils rather than clipping, which resulted in decline in the usage of clips in neurovascular surgery.

Strategic channel distribution agreements among manufacturers to bolster their regional reach

Codman Neuro entered into agreement with InNeuroCo, Inc. for the European distribution rights for intermediate catheters (ICs). Similarly, Covidien (now Medtronic) entered into an exclusive distribution agreement with Pulsar Vascular, Inc. to market and promote PulseRider in Europe, the Middle East, and Africa. PulseRider is a minimally invasive device intended for use (with embolic coils) for treatment of unruptured wide-neck intracranial aneurysms. Such strategic distribution partnership are helping market leaders to expand their global footprint.

Click To Read More On Interventional Neurology Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Near Patient Molecular Solution Market Segmentation and Analysis by Recent Trends, Development and Growth by Regions to 2018-2026

Near Patient Molecular Solution Market

Near patient molecular solution, also called point-of-care diagnosis, is a technology that helps diagnose and monitor health at the convenience of the patient. There are various innovations in healthcare such as basic health monitoring smartphone apps, wearable devices, and biosensors, which provide ease to patient in monitoring their health. The motive is to provide patients with easy access to testing solutions, with quick turnaround time and accurate results as opposed to that offered by conventional lab-based tests.

Increasing incidence of diseases such as cardiac disorders and diabetes in developing countries, growing preference for home-based point-of-care devices, advancements in technology, and wide availability of easy to use devices are spurring growth of the near patient molecular solution market. According to the institute for Health Metrics and Evaluation (IHME), the number of deaths due to cardiovascular diseases worldwide increased by 41% between 1990 and 2013, from 12.3 million to 17.3 million deaths. South Asia experienced the largest increase in total deaths, with 1.8 million more deaths in 2013 than in 1990—an alarming increase of 97%.

Request For a Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/47

Due to increasing demand for point-of-care diagnosis, manufacturing companies are focusing on developing technologies that provide quick and accurate results, with small learning curve. However, shortage of skilled staff in using these devices is expected to restrain the growth of near patient molecular solution market to a certain extent.

Near patient molecular solution market taxonomy

On the basis of technology, the near patient molecular solution market is segmented as follows:

PCR based: Idylla is a real-time PCR-based molecular diagnostic system designed in such a way that physicians have fast access to highly reliable clinical molecular diagnostic information. Treatments become more targeted to individual patient through personalized medicine.

Genetic Sequencing based: Platforms are available that enables genetic sequencing and analysis of DNA data at point of care with high accuracy. Rapid DNA analysis is expected to gain traction in the near future.

Hybridization based: Peptide nucleic acid (PNA) molecular beacon probe is used to quantify 16SrRNA of specific populations in RNA extract of environmental samples.

On the basis of application, the global near patient molecular solution market is segmented as infectious diseases testing kits, pregnancy and fertility kits, hematology testing kits, urinalysis testing kits, and glucose monitoring kits. Infectious disease kits are further sub-segmented into tuberculosis, human immunodeficiency virus (HIV), hepatitis, and malaria.

Quick turnaround times of Near Patient Molecular Solutions a boon for Hospitals and Private Clinics

End users of near patient molecular solution or POC devices include hospitals, homecare, research laboratories and diagnostic laboratories. Use of near patient molecular solutions provides fast turnaround times for physicians at outpatient care facilities

North America Prominent Market, Asia High Potential Region

North America is a potential market for molecular diagnostics kits used in the testing of infectious diseases. This is due to technological advancements in molecular diagnostic tools, high prevalence of infectious diseases, high patient awareness, and faster adoption of these devices in the region. The near patient molecular solution market in Asia is projected to witness rapid growth due to rampant research and development activities and growing awareness among the populace about infectious diseases and their diagnostic procedures. Moreover, increase in population and growing disposable income in developing countries such as India and China are expected to boost growth of the near patient molecular solution market in the near future.

Global players involved in near patient molecular solution market

Major companies operating in the global molecular diagnostics include Abbott Laboratories, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., and GenMark Diagnostics. Integration of advanced technologies in their product offerings is the major focus of companies competing in near patient molecular solution market. Abbott’s i-STAT Alinity handheld blood testing platform received CE mark in November 2016. Siemens Healthineers acquired Conworx Technology to flesh out its point-of-care informatics capabilities in November 2016. This highly lucrative market is expected to witness fast growth in the near future, fueled by increasing R&D activities by major players in order to differentiate their offerings.

Click To Read More On Near Patient Molecular Solution Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.